Search PubMed⌕ Search

PubMed · 3019888

Interference with granulocyte function by Staphylococcus epidermidis slime.

Abstract

The interaction of Staphylococcus epidermidis slime with human neutrophils (PMN) was examined by using isolated slime and allowing bacteria to elaborate slime and other extracellular products in situ. S. epidermidis slime was found to contain a chemoattractant. Incubation of PMN with 50 micrograms or more of slime per ml inhibited subsequent chemotaxis of the PMN to n-formyl-methionyl-leucyl-phenylalanine by 27% and to zymosan-activated serum by 44 to 67% with increasing slime concentrations. S. epidermidis slime stimulated little degranulation of untreated PMN. After pretreatment of PMN with 5 micrograms of cytochalasin b per ml, slime predominantly induced release of specific granule contents (33.8% lactoferrin release by 250 micrograms of slime per ml versus 10% myeloperoxidase release by 250 micrograms of slime per ml). By a surface phagocytosis assay, PMN uptake of radiolabeled S. epidermidis which were incubated for 18 h on a plastic surface for slime expression was less than that for S. epidermidis adhered to the plastic for 2 h or grown in unsupplemented nutrient broth. These results suggest that S. epidermidis slime interaction with PMN may be potentially detrimental to host defense and may contribute to the ability of this organism to persist on surfaces of foreign bodies in the vascular or central nervous system.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G M Johnson, D A Lee, W E Regelmann, E D Gray, G Peters, P G Quie. 1986. Interference with granulocyte function by Staphylococcus epidermidis slime.. https://doi.org/10.1128/iai.54.1.13-20.1986

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Influence of fractionated irradiation on neutrophilic granulocyte function.

BACKGROUND: A recent study has demonstrated that radiation therapy with single doses of up to 32 Gy has only a minor effect on neutrophilic granulocyte function. In clinical practice, by contrast, fractionated irradiation is applied. Therefore, the aim of the current study was to verify the influence of fractionated radiation therapy on granulocyte function. MATERIAL AND METHODS: Density gradient-purified granulocytes of voluntary healthy donors were used for all experiments. Granulocytes were kept in RPMI 1640 without fetal calf serum, incubated for 48 h and irradiated. Their function was assessed by measuring luminol-enhanced chemiluminescence after stimulation with phorbol myristate acid (PMA). All tests were performed at least five times. RESULTS: Relative changes (any reactive oxygen species [ROS] release before stimulation was defined as being equal to 100%) in ROS release increased after stimulation wit PMA (mean +/- SD): 0 Gy: 785 +/-, 462.2%; 2 Gy: 704.3 +/- 388.1%; 6 Gy: 1,360.3 +/- 710.5%; 12 Gy: 1,119.4 +/- 581.1%; 18 Gy: 1,087.3 +/- 622.4; 6 Gy (3 x 2 Gy): 279.4 +/- 201.1%; 12 Gy (6 x 2 Gy): 278.8 +/- 175.3%; 18 Gy (9 x 2 Gy): 84.2 +/- 41.5%. Comparing relative changes in ROS release after PMA stimulation, the differences between 0, 2, 6, 12, 18 Gy, and 6 Gy (3 x 2 Gy), 12 Gy (6 x 2 Gy), 18 Gy (9 x 2 Gy), and between 6 Gy (3 x 2 Gy), 12 Gy (6 x 2 Gy) and 18 Gy (9 x 2 Gy) proved to be significant (all p < 0.005). CONCLUSION: The study shows, that clinically used fractionated irradiation has an impact on granulocyte function, but contrary to common assumption, it is not to total dose itself but rather the fractionation which influences granulocyte function. This could have a major clinical impact on radiation treatment schemes especially for benign diseases or anti-inflammatory treatment.

Chemotaxis, Leukocyte↗

MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils.

Many neutrophil responses, including chemotaxis, exocytosis, respiratory burst activity and chemokine synthesis, are mediated by p38 MAPK. MAPK-activated protein kinase-2 (MK2) is activated by p38 MAPK in human neutrophils. The present study tested the hypothesis that MK2 mediates multiple p38 MAPK-dependent responses in human neutrophils by comparing the effect of the p38 MAPK inhibitor, SB203580, with an MK2 inhibitory peptide. Both SB203580 and MK2 inhibitory peptide attenuated respiratory burst activity, exocytosis, and chemotaxis. Lipopolysaccharide (LPS)-induced IL-8 production was inhibited by SB203580, but not by the MK2 inhibitory peptide. Inhibition of chemotaxis and respiratory burst activity by SB203580 was less than that of MK2 inhibitory peptide. Inhibition of extracellular signal-regulated kinase (ERK) activity by PD98059 attenuated superoxide release and chemotaxis, and simultaneous treatment with SB203580 and PD98059 demonstrated additive inhibition. ERK phosphorylated MK2 in vitro and activated MK2 in f-methionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils. These data suggest that MK2 mediates both ERK- and p38 MAPK-dependent neutrophil responses.

Chemotaxis, Leukocyte↗

Retinoic acid syndrome: manifestations, pathogenesis, and treatment.

All-trans retinoic acid (ATRA) is a potent differentiation agent that is effective therapy in acute promyelocytic leukaemia. Although ATRA is generally well tolerated, some patients develop retinoic acid syndrome. This syndrome is manifested by unexplained fever, weight gain, respiratory distress, interstitial pulmonary infiltrates, pleural and pericardial effusion, episodic hypotension, and acute renal failure. However, if identified early enough, effective therapy can be administered. This chapter discusses the clinical aspects and pathogenesis of retinoic acid syndrome.

Chemotaxis, Leukocyte↗